Taking Wegovy Every Other Week for Maintenance: What the Evidence Says

Wegovy is licensed for once-weekly subcutaneous injection — the every-other-week schedule is not part of the approved regimen.
Stopping or reducing frequency without clinical guidance is associated with weight regain; long-term supervised use is typically recommended.
The licensed maintenance dose is 2.4 mg weekly (with a higher 7.2 mg option now available); a prescriber decides the right dose and frequency for you.
Any decision to taper, pause or extend dosing intervals should be made with a prescriber who can review your progress and health picture.

Spreading Wegovy doses to every other week is not supported by its licensed schedule. Semaglutide is designed as a once-weekly injection, and spacing doses out further is not an approved maintenance strategy under the UK licence. That said, the question of how to sustain weight loss long-term without staying on the full dose indefinitely is one a lot of people are genuinely working through. Wegovy is a prescription-only medicine; any change to your dosing frequency is a clinical decision for your prescriber, not something to adjust independently.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the dosing interval matters — and what happens when you change it

The decision you're probably facing

You've lost the weight, or you're close. The injections have worked, and now you're wondering whether you really need to keep going every single week, or whether you could stretch to fortnightly. It's a sensible question. Every-other-week dosing would halve the cost, reduce the side-effect burden, and feel like a step towards independence from the medicine.

A question our prescribers hear most weeks is some version of this: can I just do it every two weeks now that I'm in a good place? The honest answer is that the licensed schedule doesn't allow for that flexibility, and there's a clinical reason behind that rigidity worth understanding before you decide anything.

Semaglutide has a half-life of roughly one week, which is precisely why it was designed as a once-weekly injection. At that interval, levels in the body stay relatively stable. Miss a week and the pharmacological effect begins to drop off noticeably. By day 14, the appetite-suppressing signal has weakened considerably for most people. You can read more about how the standard schedule is structured on our Wegovy doses overview.

What happens to weight when the interval changes

The STEP 1 trial, published in the New England Journal of Medicine, established that semaglutide 2.4 mg once weekly produced around 15% average weight reduction over 68 weeks. That result came from strict weekly dosing. There are no equivalent trial data for an every-other-week schedule, because it was never tested as a maintenance strategy.

What has been studied is what happens when people stop entirely. Evidence consistently shows that much of the weight lost returns within about a year of discontinuation. An every-other-week schedule sits somewhere between full treatment and stopping, and it carries a similar, if slower, trajectory towards regain for many people. The NHS England guidance on weight-management injections is clear that these medicines are expected to be used long-term as part of an ongoing supervised plan, not tapered once a target is reached.

That doesn't mean you're on this medicine forever at full dose. It means any reduction in frequency or dose should be intentional, monitored and clinically led. There's a meaningful difference between an unilateral decision to skip alternate weeks and a structured prescriber-guided conversation about what the right next step looks like for you.

What your actual options look like

If the goal is reducing the intensity of treatment while protecting what you've achieved, there are a few directions a prescriber might explore with you. One is continuing at 2.4 mg weekly. Another is stepping back to a lower maintenance dose, our page on what the Wegovy maintenance dose involves covers this in detail, including the 1 mg dose tier that some people find easier to sustain. A third is considering what a structured pause might look like under clinical supervision.

None of these paths involves simply doubling the interval on your own. Partly because the pharmacology doesn't neatly support it. But also because weight management medicines are prescription-only for good reason: the monitoring that comes with ongoing clinical review is part of what makes the treatment safe. At nume, every repeat order is individually reviewed by a GPhC-registered prescriber before it's dispensed, that's not a formality, it's the mechanism through which these kinds of questions get addressed properly.

If you're thinking about what comes after active treatment, our page on life after Wegovy is a good place to start. And if cost is part of what's driving the question, it's worth seeing what's actually included in a single transparent price before assuming the solution is stretching the doses, our cost context page sets out what to look for.

What to do before you change anything

If you're on Wegovy and tempted to adjust your schedule, the right move is to raise it with your prescriber before you change anything. Not because it's a bureaucratic hurdle. Because the conversation usually surfaces options you hadn't considered.

You may be at a dose that could legitimately be reviewed. You may be further from a healthy plateau than the scale suggests. Or you may be exactly where you think you are, and a clinical conversation will give you a clear-eyed plan for the next phase. If you're wondering whether there is a maintenance dose for Wegovy, that's a good question to bring to that conversation, and one our prescribers can help you think through properly. The NHS semaglutide guidance reinforces that dosing changes should follow prescriber advice and the Patient Information Leaflet, not personal experimentation.

What doesn't serve you is quietly skipping every other injection and waiting to see what happens. By the time the effect is obvious, you've lost several weeks of progress. Some people also ask whether taking Wegovy once a month could work as a maintenance approach, and that page sets out why the evidence doesn't support it as a straightforward swap. If you'd like to talk through your maintenance options, speak to our prescribers, we can review where you are and help you work out what comes next.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions